The development of new vaccines against Bacillus anthracis

Journal of Applied Microbiology

Volumn 91, Issue 4, 2001, Pages 609-613

  Baillie, L ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS ANTHRACIS;

BACTERIOLOGY;

ANTHRAX TOXIN; ANTHRAX VACCINE; ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; CHLORAMPHENICOL; CIPROFLOXACIN; DNA VACCINE; ERYTHROMYCIN; GENTAMICIN; LIVE VACCINE; NEOARSPHENAMINE; PENICILLIN G; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; VIRULENCE FACTOR;

BACTERIAL DISEASE; VACCINATION;

AEROSOL; ANIMAL DISEASE; ANTHRAX; ANTIBACTERIAL ACTIVITY; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERIUM CULTURE; BIOLOGICAL WARFARE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DRUG MECHANISM; EDEMA; HEAT TOLERANCE; HUMAN; INFECTION PREVENTION; IRAQ; LETHAL GENE; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; SAFETY; SPOROGENESIS; VACCINATION; VACCINE PRODUCTION;

EID: 0034785965     PISSN: 13645072     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2672.2001.01498.x     Document Type: Conference Paper

References (51)

1. Bacillus anthracis
2. Bacillus anthracis, a bug with attitude!
3. Evaluation of Bacillus subtilis strain IS53 for the production of Bacillus anthracis protective antigen
4. Development of a Bacillus subtilis based system for the expression of the protective antigen of Bacillus anthracis
5. The expression of the protective antigen of Bacillus anthracis in Bacillus subtilis
6. Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produced protective antigen
7. Studies on a protective antigen produced in vitro from Bacillus anthracis: Medium and methods of production
8. Recombinant Vaccinia virus protect against Clostridium perfringens alpha toxin
9. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax
10. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge
11. Anthrax
12. Progress in the control and research of anthrax in China
13. Human anthrax in Sivas, Turkey
14. Proteolytic inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor
15. Postexposure prophylaxis against experimental inhalation anthrax
16. Current occurrence of anthrax in man and animals
17. Treatment of anthrax
18. Protection against anthrax by vaccination with a DNA plasmid encoding anthrax protective antigen
19. Germination of Bacillus anthracis spores within aveolar macrophages
20. Anthrax: The disease in relation to vaccines
21. Anthrax pathogenesis and host response
22. Understanding Bacillus anthracis pathogenesis
23. DNA immunisation
24. Expression of the Bacillus anthracis protective antigen by Baculovirus and Vaccinia virus recombinants
25. Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis
26. Comparative efficacy of experimental anthrax vaccine against inhalation anthrax in rhesus macaques
27. Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers
28. Multiple-locus variable number tandem repeat analysis reveals genetic relationships with Bacillus anthracis
29. Anthrax (Siberian Plague)
30. Anti-microbial susceptibilityofBacillus anthracis
31. Molecular pathogenesis of Bacillus anthracis infection
32. Protective efficacy of a recombinant antigen against Bacillus anthracis challenge and assessment of immunological markers
33. Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis
34. Expression and secretion of Bacillus anthracis protective antigen in Bacillus brevis
35. Sequence and organisation of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes
36. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ release of NO and TNFα
37. Crystal structure of the anthrax toxin protective antigen
38. Human anthrax in Zimbabwe
39. Internalisation and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells
40. Distribution and economic importance of anthrax
41. Anthrax vaccines: Past, present and future
42. Anthrax is alive and well
43. Definitive identification of Bacillus anthracis - A review
44. Current status of immunisation against anthrax: Old vaccines may be here to stay for a while
45. Cloning of the protective antigen gene of Bacillus anthracis
46. Presentation of protective antigen to the mouse immune system: Immune sequelae
47. Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases
48. Expression of the protective antigen of Bacillus anthracisby Lactobacillus casei: Towards the development of an oral vaccine against anthrax
49. Iraq's biological weapons